Search Results

Lone Star Bio

TearLab® Announces Corporate Name Change to Trukera™ Medical, Positions Company for Further Expansion in Corneal Health

TearLab® Corporation, the global leader in ophthalmic point-of-care diagnostics, announced that it will be expanding its position in corneal health under the new name Trukera™ Medical.

September 7, 2022

·

3 min read

Deals

TearLab Corporation Confirms Merger Discussions

In light of recent market rumors, TearLab Corporation confirmed that TearLab is engaged in advanced discussions regarding a potential business combination whereby TearLab will be acquired at a price per share equal to $0.0586.

May 7, 2020

·

2 min read

Deals

TearLab Closes Acquisition By Accelmed Partners

TearLab Corporation (TearLab), a leader in diagnostics for dry eye disease (DED), today announced their acquisition by Accelmed Partners II (AP-II). As a newly formed private company, TearLab is now positioned to pursue further devel

July 9, 2020

·

2 min read

Press Releases

Orion Corporation: The Board of Directors of Orion Corporation decided on incentive programs for the company’s key persons

February 25, 2025

·

3 min read

Business

TearLab Corporation Reports Fourth Quarter and Full Year 2019 Financial Results

TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and twelve months ended December 31, 2019

March 5, 2020

·

5 min read

Press Releases

Hemostemix Provides Corporate Update

February 14, 2025

·

6 min read

Biotech Beach

TearLab Resubmits 510(k) for U.S. FDA Clearance of the TearLab Discovery™ MMP-9 Test

TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its 510(k) application for the potential clearance of its TearLab Discovery™ MMP-9 Test, the Company’s next-generation in-vitro diagnostic testing system.

April 22, 2020

·

2 min read

Business

TearLab Appoints Adam Szaronos as Chief Commercial Officer

TearLab Corporation (TearLab), an eye care medical device firm marketing lab-on-a-chip diagnostic technologies at the point-of-care, today announced the appointment of Adam Szaronos to the position of Chief Commercial Officer (CCO).

July 28, 2020

·

2 min read

Press Releases

Kelyniam Corporate Update

January 21, 2025

·

2 min read

Press Releases

Mesoblast Financial Results and Corporate Update Webcast

February 26, 2025

·

2 min read